125.55
price down icon5.67%   -7.545
after-market 시간 외 거래: 126.17 0.625 +0.50%
loading
전일 마감가:
$133.09
열려 있는:
$129.24
하루 거래량:
1.60M
Relative Volume:
1.28
시가총액:
$9.78B
수익:
-
순이익/손실:
$-159.39M
주가수익비율:
-35.46
EPS:
-3.5401
순현금흐름:
$-105.22M
1주 성능:
+9.64%
1개월 성능:
+21.38%
6개월 성능:
+1,688%
1년 성능:
+1,541%
1일 변동 폭
Value
$122.81
$131.02
1주일 범위
Value
$113.79
$138.49
52주 변동 폭
Value
$4.77
$138.49

Abivax Adr Stock (ABVX) Company Profile

Name
명칭
Abivax Adr
Name
전화
-
Name
주소
-
Name
직원
69
Name
트위터
Name
다음 수익 날짜
2025-12-15
Name
최신 SEC 제출 서류
Name
ABVX's Discussions on Twitter

ABVX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ABVX
Abivax Adr
125.55 10.37B 0 -159.39M -105.22M -3.5401
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.04 113.14B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
741.29 78.49B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
877.94 54.76B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
397.55 54.51B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
INSM
Insmed Inc
197.01 41.64B 447.02M -1.18B -906.14M -6.1812

Abivax Adr Stock (ABVX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-11-24 개시 Truist Buy
2025-11-06 개시 Wolfe Research Outperform
2025-10-13 개시 Barclays Overweight
2025-07-23 업그레이드 Morgan Stanley Equal-Weight → Overweight
2025-03-20 개시 Morgan Stanley Equal-Weight
2024-12-04 개시 JMP Securities Mkt Outperform
2024-07-29 개시 Laidlaw Buy
2024-05-20 개시 BTIG Research Buy
2024-04-29 개시 Guggenheim Buy
2024-04-29 개시 Piper Sandler Overweight
2023-11-14 개시 Leerink Partners Outperform
2023-11-14 개시 Morgan Stanley Equal-Weight
모두보기

Abivax Adr 주식(ABVX)의 최신 뉴스

pulisher
Dec 10, 2025

A Look at Abivax ADR (ABVX) Shares in the Recent Past Indicates Growth - setenews.com

Dec 10, 2025
pulisher
Dec 10, 2025

What's Happening With French Biotech Abivax Stock On Wednesday? - Benzinga

Dec 10, 2025
pulisher
Dec 10, 2025

Stempoint Capital LP Invests $671,000 in Abivax SA Sponsored ADR $ABVX - MarketBeat

Dec 10, 2025
pulisher
Dec 08, 2025

Abivax SA Sponsored ADR $ABVX Shares Acquired by Kennedy Capital Management LLC - MarketBeat

Dec 08, 2025
pulisher
Dec 06, 2025

Abivax SA Sponsored ADR $ABVX Shares Sold by Affinity Asset Advisors LLC - MarketBeat

Dec 06, 2025
pulisher
Dec 05, 2025

A3EWCP Stock Price and Chart — LSX:A3EWCP - TradingView

Dec 05, 2025
pulisher
Dec 05, 2025

Abivax SA Sponsored ADR $ABVX Shares Bought by Saturn V Capital Management LP - MarketBeat

Dec 05, 2025
pulisher
Dec 05, 2025

Quadrature Capital Ltd Acquires Shares of 19,367 Abivax SA Sponsored ADR $ABVX - MarketBeat

Dec 05, 2025
pulisher
Dec 04, 2025

Investors in cash trouble should check out Abivax ADR (ABVX) - setenews.com

Dec 04, 2025
pulisher
Dec 03, 2025

Abivax SA Sponsored ADR Dividends – LS:A3EWCP - TradingView

Dec 03, 2025
pulisher
Dec 03, 2025

ETFs Investing in Abivax SA Sponsored ADR Stocks - TradingView

Dec 03, 2025
pulisher
Nov 28, 2025

There is no doubt that Abivax ADR (ABVX) ticks all the boxes. - Setenews

Nov 28, 2025
pulisher
Nov 25, 2025

Abivax SA Sponsored ADR (ABVX) Receives a New Rating from Truist Financial - The Globe and Mail

Nov 25, 2025
pulisher
Nov 25, 2025

Abivax SA Sponsored ADR (NASDAQ:ABVX) Receives Average Rating of "Buy" from Analysts - MarketBeat

Nov 25, 2025
pulisher
Nov 25, 2025

Abivax SA Sponsored ADR (NASDAQ:ABVX) Receives Average Rating of “Buy” from Analysts - Defense World

Nov 25, 2025
pulisher
Nov 21, 2025

Abivax (NASDAQ:ABVX) Sees Large Volume IncreaseHere's Why - MarketBeat

Nov 21, 2025
pulisher
Nov 20, 2025

Abivax (ABVX) Stock Jumps on AstraZeneca Takeover Rumors: Outlook for November 20, 2025 - ts2.tech

Nov 20, 2025
pulisher
Nov 20, 2025

Is Abivax ADR (ABVX) positioned for future growth? - Setenews

Nov 20, 2025
pulisher
Nov 20, 2025

Nothing is Better Than Kyivstar Group Ltd (KYIV) stock at the moment - Setenews

Nov 20, 2025
pulisher
Nov 19, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), ALX Oncology Holdings (ALXO) and 60 Degrees Pharmaceuticals, Inc. (SXTP) - The Globe and Mail

Nov 19, 2025
pulisher
Nov 18, 2025

Abivax (NASDAQ:ABVX) Sets New 12-Month HighStill a Buy? - MarketBeat

Nov 18, 2025
pulisher
Nov 15, 2025

Abivax (NASDAQ:ABVX) Sees Strong Trading VolumeStill a Buy? - MarketBeat

Nov 15, 2025
pulisher
Nov 15, 2025

Abivax SA Sponsored ADR (ABVX) Upgraded to Buy: Here's What You Should Know - MSN

Nov 15, 2025
pulisher
Nov 14, 2025

Are Medical Stocks Lagging Abivax SA Sponsored ADR (ABVX) This Year? - sharewise.com

Nov 14, 2025
pulisher
Nov 13, 2025

A new trading data show Abivax ADR (ABVX) is showing positive returns. - Setenews

Nov 13, 2025
pulisher
Nov 12, 2025

Akebia Therapeutics (AKBA) Receives a Buy from BTIG - The Globe and Mail

Nov 12, 2025
pulisher
Nov 11, 2025

Abivax (NASDAQ:ABVX) Sets New 52-Week HighShould You Buy? - MarketBeat

Nov 11, 2025
pulisher
Nov 10, 2025

Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), ALX Oncology Holdings (ALXO) and Cencora (COR) - The Globe and Mail

Nov 10, 2025
pulisher
Nov 06, 2025

Get in on Abivax ADR’s (ABVX) buy-in window today! - Setenews

Nov 06, 2025
pulisher
Nov 06, 2025

Wall Street analysts’ outlook for Zevia PBC (ZVIA) - Setenews

Nov 06, 2025
pulisher
Nov 05, 2025

Positive Outlook for Abivax SA: Obefazimod’s Potential in Crohn’s Disease Drives Buy Rating - TipRanks

Nov 05, 2025
pulisher
Oct 31, 2025

What is Abivax ADR (ABVX) Stock Return on Shareholders’ Capital? - Setenews

Oct 31, 2025
pulisher
Oct 31, 2025

Abivax SA Sponsored ADR (NASDAQ:ABVX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Oct 31, 2025
pulisher
Oct 23, 2025

Abivax SA Sponsored ADR (NASDAQ:ABVX) Sees Significant Decrease in Short Interest - MarketBeat

Oct 23, 2025
pulisher
Oct 10, 2025

Leerink Partnrs Analysts Raise Earnings Estimates for Abivax - Defense World

Oct 10, 2025
pulisher
Oct 09, 2025

Abivax SA Sponsored ADR (ABVX) Receives a Rating Update from a Top Analyst - The Globe and Mail

Oct 09, 2025
pulisher
Oct 06, 2025

Abivax SA Sponsored ADR (NASDAQ:ABVX) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Oct 06, 2025
pulisher
Oct 06, 2025

Abivax Shares Surge After Strong Phase 3 Results in Ulcerative Colitis Study - MSN

Oct 06, 2025
pulisher
Oct 06, 2025

Top 1% Biotech Abivax Surges On 'Compelling' Results In A Highly Watched Disease - Investor's Business Daily

Oct 06, 2025
pulisher
Oct 03, 2025

FY2025 EPS Estimates for Abivax Boosted by Lifesci Capital - Defense World

Oct 03, 2025
pulisher
Oct 02, 2025

Abivax SA Reports Financial Results and Strategic Advances - MSN

Oct 02, 2025
pulisher
Sep 24, 2025

Abivax Reports Increased Losses but Secures Major Funding in H1 2025 - msn.com

Sep 24, 2025
pulisher
Sep 20, 2025

Abivax SA Sponsored ADR (NASDAQ:ABVX) Short Interest Up 42.1% in August - MarketBeat

Sep 20, 2025
pulisher
Sep 16, 2025

Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX), KalVista Pharmaceuticals (KALV) and Argenx Se (ARGX) - The Globe and Mail

Sep 16, 2025
pulisher
Sep 16, 2025

Abivax SA Sponsored ADR (NASDAQ:ABVX) Sees Significant Increase in Short Interest - Defense World

Sep 16, 2025
pulisher
Sep 16, 2025

Abivax SA Sponsored ADR (NASDAQ:ABVX) Receives $95.14 Consensus PT from Brokerages - MarketBeat

Sep 16, 2025
pulisher
Sep 14, 2025

Abivax (NASDAQ:ABVX) Shares Gap Down – What’s Next? - Defense World

Sep 14, 2025
pulisher
Sep 13, 2025

Octagon Capital Advisors LP Makes New $7.69 Million Investment in Abivax SA Sponsored ADR $ABVX - MarketBeat

Sep 13, 2025
pulisher
Sep 12, 2025

Abivax SA Sponsored ADR (NASDAQ:ABVX) Short Interest Down 38.0% in August - MarketBeat

Sep 12, 2025
pulisher
Sep 11, 2025

Abivax SA Sponsored ADR (NASDAQ:ABVX) Given Average Rating of “Buy” by Brokerages - Defense World

Sep 11, 2025

Abivax Adr (ABVX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
자본화:     |  볼륨(24시간):